Analytical Data
-
Gene name
TSNAX
- Application
-
Alternative Names
TSNAX；TRAX；Translin-associated Protein X
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q99598
-
Expression Region
1-290aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSNKEGS GGFRKRKHDN FPHNQRREGK DVNSSSPVML AFKSFQQELD ARHDKYERLV KLSRDITVES KRTIFLLHRI TSAPDMEDIL TESEIKLDGV RQKIFQVAQE LSGEDMHQFH RAITTGLQEY VEAVSFQHFI KTRSLISMDE INKQLIFTTE DNGKENKTPS SDAQDKQFGT WRLRVTPVDY LLGVADLTGE LMRMCINSVG NGDIDTPFEV SQFLRQVYDG FSFIGNTGPY EVSKKLYTLK QSLAKVENAC YALKVRGSEI PKHMLADVFS VKTEMIDQEE GIS
-
Molecular Weight
35 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TSNAX, or TANS-Specific Nuclear RNA Associated Protein, has garnered significant attention in recent years due to its potential roles in various cellular processes and contributions to disease mechanisms. Recent studies have suggested that TSNAX is involved in RNA binding and processing, influencing gene expression and stability, which has implications in cancer and neurodegenerative diseases. Its overexpression has been linked to tumor progression, while mutations or dysregulation in its expression may lead to neurodegenerative disorders. Understanding the structural and functional aspects of TSNAX, including its interactions with other proteins and RNA molecules, is crucial for elucidating its role in cellular physiology. There is a growing interest in harnessing TSNAX as a therapeutic target or biomarker in oncology and neurology, leading researchers to explore its potential in novel treatment strategies. Given its multifaceted roles, further investigation into TSNAX's biological functions, regulatory mechanisms, and involvement in disease pathways could pave the way for innovative interventions and enhance our understanding of complex biological systems.
